BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11222389)

  • 1. Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults.
    Smith MT; Wang Y; Kane E; Rollinson S; Wiemels JL; Roman E; Roddam P; Cartwright R; Morgan G
    Blood; 2001 Mar; 97(5):1422-6. PubMed ID: 11222389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.
    Smith MT; Wang Y; Skibola CF; Slater DJ; Lo Nigro L; Nowell PC; Lange BJ; Felix CA
    Blood; 2002 Dec; 100(13):4590-3. PubMed ID: 12393620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
    Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
    Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
    Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
    Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between GSTT1, GSTM1 and NQO1 gene polymorphism and acute myeloid leukemia and recurrent chromosome translocations].
    Yang L; Zhang Y; Zhang MR; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2312-6. PubMed ID: 16321221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
    Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
    Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients.
    Malik E; Cohen SB; Sahar D; Dann EJ; Rund D
    Haematologica; 2006 Jul; 91(7):956-9. PubMed ID: 16818284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
    Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
    Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8.
    Zachaki S; Stavropoulou C; Koromila T; Manola KN; Kalomoiraki M; Daraki A; Koumbi D; Athanasiadou A; Kanavakis E; Kollia P; Sambani C
    Leuk Res; 2013 Jul; 37(7):742-6. PubMed ID: 23643325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
    Siegel D; McGuinness SM; Winski SL; Ross D
    Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
    Li C; Liu Y; Wei S; Zhou Y
    Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
    Bolufer P; Collado M; Barragán E; Cervera J; Calasanz MJ; Colomer D; Roman-Gómez J; Sanz MA
    Haematologica; 2007 Mar; 92(3):308-14. PubMed ID: 17339179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
    Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
    Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
    Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
    Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism of MAO-B gene and NAD(P)H: quinone oxidoreductase gene in Parkinson's disease].
    Shao M; Liu Z; Tao E; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):122-4. PubMed ID: 11295131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
    Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
    Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees.
    Goto Y; Hamajima N; Honda H; Matsuo K; Yamamoto K; Tamakoshi A; Ando T; Goto H
    Gastric Cancer; 2005; 8(1):12-7. PubMed ID: 15747169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.